Pradelli, L., Villa, S. and Castaman, G. (2018) “Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model”, Farmeconomia. Health economics and therapeutic pathways, 19(1). doi: 10.7175/fe.v19i1.1328.